HNSCC

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  

HNSCC
Apr 29, 2025, 04:40 | Blog
Amol Akhade: Exciting update from AACR25
Amol Akhade, Consultant Medical Oncologist and Hemato-oncologist at Suyog Cancer Clinics, posted on LinkedIn: "Exciting…
Apr 28, 2025, 13:16 | Insight
Amol Akhade: Insights on KEYNOTE-689 immunotherapy breakthrough in non-metastatic HNSCC at AACR 2025
Amol Akhade, Consultant Medical Oncologist and Hemato-oncologist at Suyog Cancer Clinics, shared a post on…
Apr 27, 2025, 16:13 | Blog
Luigi Lorini: Sharing my thoughts on crucial topics about HNSCC during the latest ESMO meeting in Barcelona
Luigi Lorini, Medical Oncologist at Humanitas Research Hospital, shared a post on LinkedIn: "What’s next…
Apr 26, 2025, 05:17 | Blog
Bernard A. Fox: Heading to AACR2025 to talk about our work on cancer immunotherapy for HNSCC
Bernard A. Fox, Co-Founder / President / CEO at UbiVac, posted on X: "Heading to…
Apr 16, 2025, 17:19 | Blog
Testing a new treatment approach for HNSCC - ECOG-ACRIN Cancer Research Group
ECOG-ACRIN Cancer Research Group shared a post on X: "April is Head and Neck Cancer…
Apr 5, 2025, 15:21 | Blog
Head and Neck Cancer: Hidden Risks, Mutations and Outcomes
Head and neck cancer (HNSCC) is tough—not just medically, but emotionally, physically, and financially. Treatments…
Mar 31, 2025, 18:27 | Blog
Bernard A. Fox: UbiVac Seeks Support and Partners to Bring DPV-001 Immunotherapy to Pediatric Cancer Trials
Bernard A. Fox, Co-Founder, President, and CEO of UbiVac, shared a post on LinkedIn: "Fulfilling…
Mar 28, 2025, 14:03 | Blog
Shankar Siva: OMET trial in oligometastatic HNSCC
Shankar Siva, Radiation Oncologist at Peter MacCallum Cancer Centre, shared a post on X: "OMET…
Mar 27, 2025, 18:52 | Blog
Bernard A. Fox: New Cancer Treatment Has Tripled Response Rates for HNSCC
Bernard A. Fox, Co-Founder, President, and CEO of UbiVac, shared a post on LinkedIn: "I…
Mar 27, 2025, 10:21 | Blog
Bernard Fox: A promise to pediatric cancer patients before retirement
Bernard Fox, Co-Founder, President and CEO of UbiVac, shared a post on LinkedIn: "I posted…
Feb 27, 2025, 10:03 | Blog
Tanja Obradovic: New option of immunotherapy for HNSCC is on the horizon
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON PLCh, shared a post on…
Feb 13, 2025, 17:58 | Blog
Bernard A. Fox: We need to do more for every patient fighting cancer
Bernard A. Fox, Co-Founder, President, and CEO of UbiVac, shared on LinkedIn: "A friend of mine…
Dec 23, 2024, 16:55 | Insight
Bernard Fox: Earle A. Chiles Research Institute's tripling of response rates for patients with head and neck cancer
Bernard Fox, Co-Founder, President and CEO of UbiVac, shared a post on LinkedIn by Earle…
Nov 18, 2024, 15:30 | Insight
Gustavo Viani: Radiotherapy with durvalumab vs cetuximab advanced HNSCC
Gustavo Viani, Associate Professor in the Department of Medical Imaging, Hematology, and Oncology at Hospital…
Sep 25, 2024, 18:29 | Insight
Tanja Obradovic: Ligufalimab plus ivonescimab combined with chemo in the first-line CRC patients
Tanja Obradovic shared a post on LinkedIn: "Tackling large medical need in microsatellite stable (MSS)…
Aug 19, 2024, 16:20 | Blog
Javad Arabpour: PD-L1's Hidden Talent
Javad Arabpour, Journal reviewer at Elsevier, shared a post on LinkedIn: "PD-L1's Hidden Talent: Beyond…
Aug 9, 2024, 05:21 | Insight
Spatial profiling and phenotyping of tertiary lymphoid aggregates in head and neck cancer
Queensland Spatial Biology Centre shared a post on X about a recent paper by Habib…
Jun 10, 2024, 02:29 | Blog
Susanna Flach: Incredible experience to present our work at this year's ASCO meeting
Susanna Flach, Fellow at DKTK School of Oncology, shared on X: "Incredible experience to present…
Jun 7, 2024, 20:40 | Blog
Secondary analysis of a prospective, phase II RCT for metastatic HNSCC - Memorial Sloan Kettering Radiation Oncology
Memorial Sloan Kettering Radiation Oncology shared on X: "New from Drs James Janopaul-Naylor and Sean…
May 12, 2024, 14:34 | Societies
Tom Powles talks to Amanda Psyrri about immune cell-related biomarkers in HNSCC - ESMO
ESMO - European Society for Medical Oncology shared on LinkedIn: “Latest podcast Annals of Oncology…
Apr 23, 2024, 20:20 | Opinion
Fabio Ynoe de Moraes: This study established a Latin American guideline for care of patients with head and neck cancer
Fabio Ynoe de Moraes, Radiation Oncologist and Innovation Professor at Queen's University, shared on LinkedIn:…
Apr 20, 2024, 17:04 | Blog
Caroline Hoffmann: Guidelines for Optimizing NBTXR3 Nanoparticle Injection in Head and Neck Cancer- A Collaborative Achievement
Caroline Hoffmann, Head of Oncology at Owkin, posted on LinkedIn: "The consensus guidelines describing the…
Mar 11, 2024, 18:07 | Insight
Mathieu Sertorio: The effects of proton therapy on exosome production in HNSCC cells
Mathieu Sertorio, Assistant Professor Research at University of Cincinnati Department of Radiation Oncology, posted on LinkedIn:…
Jan 20, 2024, 18:02 | Insight
Nils Nicolay: Alexander Rühle was awarded the research award of the Roland Ernst Stiftung at the Research Festival for Life Sciences
Nils Nicolay, Professor and Chair, Department of Radiation Oncology, University of Leipzig Medical Center, recently…
Oct 22, 2023, 14:50 | Blog
Nils Nicolay: The first data from our randomized APCOT trial
Nils Nicolay, Chair of the Department of Radiation Oncology at the University of Leipzig Medical…
All: 25 Posts: 1 - 100
Special Coverage